Mitochondrial oxidative phosphorylation controls cancer cell's life and death decisions upon exposure to MAPK inhibitors

Although MAPK pathway inhibitors are becoming a promising anticancer strategy, they are insufficient to fully eliminate cancer cells and their long-term efficacy is strikingly limited in patients with BRAF-mutant melanomas. It is well established that BRAF inhibitors (BRAFi) hamper glucose uptake be...

Descripción completa

Detalles Bibliográficos
Autores principales: Corazao-Rozas, Paola, Guerreschi, Pierre, André, Fanny, Gabert, Pierre-Elliott, Lancel, Steve, Dekiouk, Salim, Fontaine, Delphine, Tardivel, Meryem, Savina, Ariel, Quesnel, Bruno, Mortier, Laurent, Marchetti, Philippe, Kluza, Jérome
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129946/
https://www.ncbi.nlm.nih.gov/pubmed/27250023
http://dx.doi.org/10.18632/oncotarget.7790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5129946/
https://www.ncbi.nlm.nih.gov/pubmed/27250023
http://dx.doi.org/10.18632/oncotarget.7790

Ejemplares similares